These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients]. Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406 [TBL] [Abstract][Full Text] [Related]
3. Possible ziprasidone-induced mania. Larson MF; Hauser A J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565 [No Abstract] [Full Text] [Related]
4. Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. Vieta E; Ramey T; Keller D; English PA; Loebel AD; Miceli J J Psychopharmacol; 2010 Apr; 24(4):547-58. PubMed ID: 19074536 [TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder. Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985 [TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia and ziprasidone. Rosenquist KJ; Walker SS; Ghaemi SN Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846 [No Abstract] [Full Text] [Related]
8. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge. Gray NS Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855 [TBL] [Abstract][Full Text] [Related]
9. Ziprasidone monotherapy in bipolar II depression: an open trial. Liebowitz MR; Salmán E; Mech A; Dunner D; Johnson AE; Akhtar J; Pratap R J Affect Disord; 2009 Nov; 118(1-3):205-8. PubMed ID: 19264363 [TBL] [Abstract][Full Text] [Related]
10. Ziprasidone-induced hyperprolactinemia: a case report. Citil DY; Selçuk E; Karlidağ R; Unal S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):905-6. PubMed ID: 18276052 [No Abstract] [Full Text] [Related]
11. Ziprasidone-associated pedal edema in the treatment of schizophrenia. Ku HL; Su TP; Chou YH Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468 [TBL] [Abstract][Full Text] [Related]
12. The highest intentional ziprasidone overdose was not fatal. Prieto T; Benabarre A; Bernardo M Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953 [No Abstract] [Full Text] [Related]
13. Ziprasidone- and lithium-induced neuroleptic malignant syndrome. Borovicka MC; Bond LC; Gaughan KM Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776 [TBL] [Abstract][Full Text] [Related]
14. Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report. Anghelescu I; Wolf J J Clin Psychiatry; 2004 Sep; 65(9):1286-7. PubMed ID: 15367061 [No Abstract] [Full Text] [Related]
15. Sudden akathisia after a ziprasidone dose reduction. Oral ET; Altinbas K; Demirkiran S Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883 [No Abstract] [Full Text] [Related]
16. Ziprasidone-induced galactorrhea: a case report. Kopecek M; Bares M; Mohr P Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024 [TBL] [Abstract][Full Text] [Related]
17. Ziprasidone-induced tardive laryngeal dystonia: a case report. Tsai CS; Lee Y; Chang YY; Lin PY Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661 [TBL] [Abstract][Full Text] [Related]
18. Ziprasidone induction of hypomania in depression? Davis R; Risch SC Am J Psychiatry; 2002 Apr; 159(4):673-4. PubMed ID: 11925314 [No Abstract] [Full Text] [Related]